4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026442
Options or other derivatives
- Chief Operating Officer acquired 117,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BILINSKY IGOR Chief Operating Officer | 2026-03-09 | Grant or award · Restricted Stock Units | +117,500 | 117,500 | D: show line 1 in the form |
Loading xslF345X05/tm268453-1_4seq1.xml…